current management of stage iiia non-small cell lung cancer: a changing paradigm (november 10, 2022)
Published 1 year ago • 5.3K plays • Length 58:15Download video MP4
Download video MP3
Similar videos
-
5:54
treating unresectable stage iii nsclc: a focus on stage iiia disease
-
9:36
gracecast-021_lung-cancer_stage iiia management options
-
6:05
treatment and management of non-small cell lung cancer (nsclc)
-
15:54
gracecast-075_lung-cancer_ccilc - optimal treatment for stage iiia n2 node-positive nsclc
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
2:30
improving the staging and diagnosis of patients with stage iii/iv non-small cell lung cancer
-
7:24
debate: surgery for stage iiia patients with lung cancer? - no
-
1:14
what are my options for treatment and management of non-small cell lung cancer (nsclc)?
-
3:32
rapid recommendation update from asco for stage ib-iiia nsclc
-
1:30
a shifting paradigm: lung cancer
-
22:53
paradigm changes in the perioperative setting for non-small cell lung cancer - karen reckamp, md
-
7:31
current management of oncogene-driven nsclc
-
2:54
current frontline management of small cell lung cancer
-
12:41
debate: surgery for stage iiia patients with lung cancer? - yes
-
3:00
neoadjuvant chemotherapy vs. chemo/radiation for stage iiia nsclc
-
1:05:29
can the addition of immunotherapy to multimodal management of stage i-iii nsclc improve outcomes?
-
6:06
stage iii nsclc: when to start durvalumab
-
2:37
overall management for stage iiia disease
-
2:29
understanding lung cancer survival rate